The Relationship Between Obesity and Atherosclerotic Progression and Prognosis Among Patients With Coronary Artery Bypass Grafts

Journal of the American College of Cardiology - Tập 52 - Trang 620-625 - 2008
Christina C. Wee1, Saket Girotra2, Amy R. Weinstein1, Murray A. Mittleman3,4, Kenneth J. Mukamal1
1Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
2Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
3Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
4Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts

Tài liệu tham khảo

Wilson, 2002, Overweight and obesity as determinants of cardiovascular risk: the Framingham experience, Arch Intern Med, 162, 1867, 10.1001/archinte.162.16.1867 Ogden, 2006, Prevalence of overweight and obesity in the United States, 1999–2004, JAMA, 295, 1549, 10.1001/jama.295.13.1549 Gregg, 2005, Secular trends in cardiovascular disease risk factors according to body mass index in US adults, JAMA, 293, 1868, 10.1001/jama.293.15.1868 McTigue, 2006, Mortality and cardiac and vascular outcomes in extremely obese women, JAMA, 296, 79, 10.1001/jama.296.1.79 Yarnell, 2000, Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study, J Epidemiol Community Health, 54, 344, 10.1136/jech.54.5.344 Folsom, 1998, Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites, Am J Epidemiol, 148, 1187, 10.1093/oxfordjournals.aje.a009608 Kim, 2003, Obesity and the risk of early and late mortality after coronary artery bypass graft surgery, Am Heart J, 146, 555, 10.1016/S0002-8703(03)00185-6 Jin, 2005, Is obesity a risk factor for mortality in coronary artery bypass surgery?, Circulation, 111, 3359, 10.1161/CIRCULATIONAHA.104.489880 Van Gaal, 2006, Mechanisms linking obesity with cardiovascular disease, Nature, 444, 875, 10.1038/nature05487 Greenberg, 2006, Obesity and the role of adipose tissue in inflammation and metabolism, Am J Clin Nutr, 83, 461S, 10.1093/ajcn/83.2.461S Birkmeyer, 1998, Obesity and risk of adverse outcomes associated with coronary artery bypass surgery, Circulation, 97, 1689, 10.1161/01.CIR.97.17.1689 Yap, 2007, Obesity and early complications after cardiac surgery, Med J Aust, 186, 350, 10.5694/j.1326-5377.2007.tb00935.x Gruberg, 2005, Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: the obesity paradox II?, Am J Cardiol, 95, 439, 10.1016/j.amjcard.2004.10.007 Hamman, 2006, Effect of body mass index on risk of long-term mortality following coronary artery bypass grafting, Am J Cardiol, 98, 734, 10.1016/j.amjcard.2006.04.008 Gurm, 2002, The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization, J Am Coll Cardiol, 39, 834, 10.1016/S0735-1097(02)01687-X 1997, The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts, N Engl J Med, 336, 152 Ridker, 2005, C-reactive protein levels and outcomes after statin therapy, N Engl J Med, 352, 20, 10.1056/NEJMoa042378 Campeau, 1999, Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors, Circulation, 99, 3241, 10.1161/01.CIR.99.25.3241 Knatterud, 2000, Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial, Circulation, 102, 157, 10.1161/01.CIR.102.2.157 2000 Domanski, 2000, Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial, J Am Coll Cardiol, 36, 1877, 10.1016/S0735-1097(00)00973-6 1979, The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program, J Chronic Dis, 32, 609, 10.1016/0021-9681(79)90092-4 Curtis, 2005, The obesity paradox: body mass index and outcomes in patients with heart failure, Arch Intern Med, 165, 55, 10.1001/archinte.165.1.55 Hall, 2005, The paradox of obesity in patients with heart failure, J Am Acad Nurse Pract, 17, 542, 10.1111/j.1745-7599.2005.00084.x Nigam, 2006, Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death, Int J Cardiol, 110, 153, 10.1016/j.ijcard.2005.06.040 Kalantar-Zadeh, 2005, Survival advantages of obesity in dialysis patients, Am J Clin Nutr, 81, 543, 10.1093/ajcn/81.3.543 Lavie, 2003, Body composition and prognosis in chronic systolic heart failure: the obesity paradox, Am J Cardiol, 91, 891, 10.1016/S0002-9149(03)00031-6 Wilson, 1989, Body weight in chronic obstructive pulmonary disease, Am Rev Respir Dis, 139, 1435, 10.1164/ajrccm/139.6.1435 Rana, 2004, Obesity and the risk of death after acute myocardial infarction, Am Heart J, 147, 841, 10.1016/j.ahj.2003.12.015 Knatterud, 2003, Angiographic changes in saphenous vein grafts are predictors of clinical outcomes, Am Heart J, 145, 262, 10.1067/mhj.2003.113